Aducanumab: A Deep Dive into BIIB037 and its Impact The drug, initially known as BIIB037, is a notable endeavor to combat mild Alzheimer's condition. Designed by Biogen, aducanumab works by clearing amyloid plaques – https://www.targetmol.com/compound/aducanumab